CDK4 and breast carcinoma: Disorders in cell-cycle-related pathways have key influences on breast cancer prognosis, and our feature selection result highlights that CDK1, CDK4, AURKA, and PLK1 may play vital roles in the complex cell cycle regulatory network, which in turn affects breast cancer prognosis.